(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

THERAKANN PHARMACEUTICALS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

THERAKANN PHARMACEUTICALS

ST13

US500000079382835

Class

3, 5, 31, 35

Filing

79382835

Registration

7691265

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

04/03/2026

Trademark type

Combined

Nice classes

3, 5, 31, 35

Filing date

07/21/2023

Registration date

02/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/18/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

GR

Examiner

YE, CINDY K

Law office

N80

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "THERAKANN PHARMACEUTICALS", where "THERA" and "PHARMACEUTICALS" are in black and "KANN" is in blue. To the left of the wording is a circular design consisting of a black crescent shape on the left and a light and dark blue crescent shape in the form of a human on the right.

Holders and representatives

Holders

T. A. (pessoa física)

Representatives

Anastasios G. Garbis Garbis Law, LLC

Technical classification

Nice Classes

Class 3Class 5Class 31Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 3

Essential oils; aromatic essential oils; essential oils for cosmetic purposes; natural essential oils; essential oils and plant extracts sold as integral components of cosmetic use

Class 5

Medicinal oilsother than essential oils; plant extractsother than essential oilsfor pharmaceutical purposes; plant and herb extractsother than essential oilsfor medicinal purposes

Class 31

Cannabisunprocessed; Dried cannabis plants; loose hemp for use as animal bedding; all of the foregoing featuring ingredients derived solely from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

Class 35

Retail store services and wholesale store services and online wholesale store services and retail store services featuring essential oilsaromatic essential oilsessential oils for cosmetic purposesnatural essential oilsessential oils and plant extracts for cosmetic usemedicinal oilsplant extracts for pharmaceutical purposesplant and herb extracts for medicinal purposesloose hemp for use as animal bedding

Publications

History of USPTO decisions and trademark events.

26 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/10/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

08/31/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

08/31/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/18/2025

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/26/2025

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/08/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/08/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/18/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/31/2024

PUBO

PUBLISHED FOR OPPOSITION

12/31/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/25/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/22/2024

DOCK

ASSIGNED TO EXAMINER

10/15/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/10/2024

RFNT

REFUSAL PROCESSED BY IB

04/30/2024

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/10/2024

RFRR

REFUSAL PROCESSED BY MPU

04/10/2024

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/22/2024

CNRT

NON-FINAL ACTION WRITTEN

03/21/2024

DOCK

ASSIGNED TO EXAMINER

03/18/2024

MAFR

APPLICATION FILING RECEIPT MAILED

11/18/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/14/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/09/2023

Continuous trademark protection

Get notified about every new filing that threatens THERAKANN PHARMACEUTICALS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.